About Zen-Bio
Zen-Bio is a company based in Durham (United States) founded in 1995 was acquired by BioIVT in August 2024. Zen-Bio offers products and services including Blood/Serum Products, Cell Extracts, Human Exosomes, Labware, and Media. Zen-Bio operates in a competitive market with competitors including Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Rules-Based Medicine, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zenbio, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Zen-Bio
Zen-Bio offers a comprehensive portfolio of products and services, including Blood/Serum Products, Cell Extracts, Human Exosomes, Labware, and Media.
Provides human and animal blood components for research use.
Offers extracts from human tissues for scientific studies.
Delivers exosomes from stem cells for regenerative research.
Supplies ECM coated plastics for cell culture applications.
Formulates media for optimal cell growth in experiments.
Provides kits for testing compounds in metabolic diseases.
Funding Insights of Zen-Bio
Investors in Zen-Bio
Zen-Bio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and BioIVT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Provider of in vitro diagnostic products and assay services
|
Locked | Locked | Locked |
Investor details for Zen-Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zen-Bio
Investment portfolio details for Zen-Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zen-Bio
Detailed financials for Zen-Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zen-Bio Comparisons
Peer comparison for Zen-Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zen-Bio
Zen-Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Rules-Based Medicine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ex-vivo human tissue studies are performed for preclinical drug discovery.
|
|
| Locked | Locked | Locked |
Cardiac safety testing is conducted using iPS-derived heart cells.
|
|
| Locked | Locked | Locked |
Ion channel screening and cardiac safety profiling services are provided.
|
|
| Locked | Locked | Locked |
Developer of transformational medicines for neurological disorders
|
|
| Locked | Locked | Locked |
Multiplexed immunoassays for protein biomarkers are developed via proprietary platform.
|
Detailed competitors of Zen-Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zen-Bio
Complete news archive for Zen-Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zen-Bio
Zen-Bio was founded in 1995 and raised its 1st funding round 13 years after it was founded.
Zen-Bio is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Founded in 1995 and based in Durham, United States, Zen-Bio operates in the biotechnology sector, focusing on metabolic diseases and cosmeceuticals. Human cell-based products, including cells, tissues, and serum from diverse donor populations and disease states such as type II diabetes and hypertension, are supplied. Contract research services, cell-based assay development, custom consultations, cell characterization, and molecular biology services are offered to support therapy development.
Zen-Bio's top competitors include Metrion Biosciences, Quiver Bioscience and Anabios.
Zen-Bio offers Blood/Serum Products, Cell Extracts, Human Exosomes, Labware, and 2 more products and services.